Cystic Fibrosis (CF) is a genetic disorder primarily affecting the lungs but also poses significant challenges to other parts of the body like the pancreas, liver, kidneys, and intestine. With thousands impacted globally, understanding this disease is essential for those aiming to combat it and improve the lives of patients.
What is Cystic Fibrosis?
CF is caused by mutations in the CFTR gene, resulting in a dysfunction in the cells responsible for producing mucus, sweat, and the substances secreted in the digestive system. In patients suffering from CF, these fluids become thick, heavy and sticky. Within the lungs, this causes a blockage of the airways, leading to frequent respiratory infections and over time, lung damage.
How does CF affects the body?
Beyond the lungs, CF can have several other implications:
- Digestive System: The thick mucus can block channels in the pancreas, preventing digestive enzymes from reaching the small intestine. Without these enzymes, the body cannot properly absorb nutrients, leading to problems such as malnutrition and diabetes.
- Reproductive System: In males, CF can impact fertility, while in females, it can make pregnancy more challenging.
- Bones and Joints: CF patients might experience joint pains and are at risk of low bone density.
Why is CF such a complex disease?
Every individual with CF might showcase a combination of symptoms that varies in severity. Additionally, continuous research is being conducted to understand the various genetic mutations associated with the disease, making the landscape of treatment and research ever-evolving.
CF is a multifaceted disorder demanding multidisciplinary care and individualized attention. At VG2D Pharma, we’re committed to pushing the boundaries of research to provide innovative solutions to CF patients and their families. Stay tuned for more on our advancements in this area.
